TrialAnnals of the rheumatic diseases2012

Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE.

Paul P Tak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.